{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:06:02Z","timestamp":1740107162575,"version":"3.37.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs","doi-asserted-by":"publisher","award":["CNTO1959PRP2001"],"award-info":[{"award-number":["CNTO1959PRP2001"]}],"id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Eli Lilly and Company,United States","award":["1F-US-1003"],"award-info":[{"award-number":["1F-US-1003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02682-7","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T17:01:43Z","timestamp":1690995703000},"page":"2933-2935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The individual Pityriasis Rubra Pilaris area and severity index (iPRPASI): validity, reliability, and responsiveness of a novel patient-reported severity tool"],"prefix":"10.1007","volume":"315","author":[{"given":"Connie","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teri M.","family":"Greiling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"issue":"5","key":"2682_CR1","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/bjd.21708","volume":"187","author":"BW Boudreaux","year":"2022","unstructured":"Boudreaux BW, Pincelli TP, Bhullar PK, Patel MH, Brumfiel CM, Li X, Heckman MG, Pittelkow MR, Mangold AR, Sluzevich JC (2022) Secukinumab for the treatment of adult-onset pityriasis rubra pilaris: a single-arm clinical trial with transcriptomic analysis. Br J Dermatol 187(5):650\u2013658. https:\/\/doi.org\/10.1111\/bjd.21708","journal-title":"Br J Dermatol"},{"issue":"8","key":"2682_CR2","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1038\/jid.2013.138","volume":"133","author":"L Chularojanamontri","year":"2013","unstructured":"Chularojanamontri L, Griffiths CE, Chalmers RJ (2013) The Simplified Psoriasis Index (SPI): a practical tool for assessing psoriasis. J Invest Dermatol 133(8):1956\u201362. https:\/\/doi.org\/10.1038\/jid.2013.138","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2682_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1001\/jamadermatol.2020.0932","volume":"156","author":"D Haynes","year":"2020","unstructured":"Haynes D, Strunck JL, Topham CA, Ortega-Loayza AG, Kent G, Cassidy PB, Hu R, Choate K, Wang Z, Liu Y, Greiling TM (2020) Evaluation of Ixekizumab treatment for patients with pityriasis rubra pilaris: a single-arm trial. JAMA Dermatol 156(6):668\u2013675. https:\/\/doi.org\/10.1001\/jamadermatol.2020.0932","journal-title":"JAMA Dermatol"},{"issue":"6","key":"2682_CR4","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/bjd.21792","volume":"187","author":"A Ji-Xu","year":"2022","unstructured":"Ji-Xu A, Lei DK, Worswick S, Maloney NJ, Kim MM, Cutler L (2022) Patient and disease characteristics associated with psychiatric symptoms and impaired quality of life in pityriasis rubra pilaris. Br J Dermatol 187(6):1024\u20131026. https:\/\/doi.org\/10.1111\/bjd.21792. (Epub 2022 Aug 18 PMID: 35895853)","journal-title":"Br J Dermatol"},{"key":"2682_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.107","author":"RC Velasco","year":"2023","unstructured":"Velasco RC, Cutler B, McCue W, Greiling TM (2023) The comprehensive impact of pityriasis rubra pilaris on physical symptoms, mental health, and activities of daily living: a mixed methods study. JEADV Clin Pract. https:\/\/doi.org\/10.1002\/jvc2.107","journal-title":"JEADV Clin Pract"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02682-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02682-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02682-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:03:00Z","timestamp":1698649380000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02682-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":5,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2682"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02682-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"type":"electronic","value":"1432-069X"}],"subject":[],"published":{"date-parts":[[2023,8,2]]},"assertion":[{"value":"13 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Teri Greiling has received research grants to study PRP from Eli Lilly and Co, Janssen Scientific Affairs, and Janssen Biotech Inc; consulted with AbbVie; and is an author on PRP for UpToDate and VisualDx. Connie Shao and Rose Velasco declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}